Morepen launches first US prescription generic, shares rise 5%
Morepen Laboratories on Monday, 9 November, launched its first prescription generic product, Desloratadine Tablets USP, 5 mg, in the US market through its wholly owned subsidiary Morepen Bio Inc. The product is…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.